While the presence of chromogranin A and synaptophysin expression suggests NED, it does not necessarily mean NEPC; immunohistochemical analysis of metastatic hormone-sensitive prostate cancer reveals that 61% of primary cancer specimens are positive for chromogranin A [12]. This evidence concerns the gene CHGA and cancer.